Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues. New research is raising the prospect of ...

Autoimmune disease hair loss can happen with alopecia areata, lupus, thyroid diseases, rheumatoid arthritis, Crohn’s disease, and scalp psoriasis. Each disease has different effects, ...

Thyroid disorders, polycystic ovary syndrome (PCOS), autoimmune diseases, osteoporosis, and iron deficiency anaemia are some ...

Imagine waking up already feeling drained, as if you never slept at all. Or noticing that your hands feel inexplicably stiff and swollen, making simple tasks like opening a jar or even typing feel ...

This is read by an automated voice. Please report any issues or inconsistencies here. There are more than 100 autoimmune diseases, affecting tens of millions as cases continue to rise, and 4 in 5 ...

A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.

Konig and Green are among the champions of this effort which The AP calls "a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus, and other devastating autoimmune ...

Chronic inflammatory demyelinating polyradiculoneuropathy is a rare autoimmune-related condition that affects nerve signaling ...

Q: How often are multiple sclerosis (MS) and Type 1 diabetes seen in one individual? In my experience, MS specialists are not ...

There are more than 100 different types of autoimmune diseases. While an estimated more than 10 million individuals globally ...

People with an autoimmune disease have almost twice the risk of developing an affective disorder, which includes depression, anxiety, and bipolar disorder, according to a new study. The findings ...

A herpes zoster vaccine is safe in adults with autoimmune rheumatic disease and elicits a strong immune response, but responses are weaker in those on rituximab or mycophenolate, per a phase 4 study.